GLPwatch
Sustained weight loss after treatment with a glucagon-like peptide-1 receptor agonist in an obese patient with schizophrenia and type 2 diabetes.
Am J Psychiatry · 2013
Last updated 2026-05-28| Journal | Am J Psychiatry, 2013 |
|---|---|
| Citations | 21 |
| Relative citation ratio | 0.78 |
| NIH percentile | 42 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes, Obesity |
Full record and abstract on PubMed 23732970 ↗